English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Lactococcus lactis, a nonpathogenic bacterium has been used widely as a vector to deliver antigens to the mucosa; one of the principal threats to world health is AIDS and HIV infection, involving the passage of the virus across a mucosal surface. We used L. lactis to express V3 loop from HIV-1, A2B subunit of cholera toxin and their fusion with one or two loops V3 (V3A2B and V3V3A2B). Six-weeks-old Balb/c mice were orally immunized with the recombinant bacteria. Samples of serum, intestinal washes and PBMC lymphocytes were collected to detect IgA and IgG anti-V3, and IL-2 respectively. The recombinants that express the V3 alone or fused to the A2B induced anti-V3 IgA antibodies and anti-V3 IgG antibodies in serum and intestinal washes but recombinant V3V3A2B was the most efficient and the only one that induced the expression of IL-2 in PBMC when compared with the controls (p<0.05). We induced anti V3 IgG and IgA and IL-2 in mice immunized with L. lactis recombinants that express the antigen V3 fused to A2B subunit of CT; which suggests that this strategy could be used to induce immune response specific of HIV.   Key words: HIV, vaccines, Lactococcus lactis, lactic acid bacteria, mucosal immunity.

Expression of two loopsV3 from HIV-1 fused to cholera toxin A2B subunit using Lactococcus lactis as a vector to induce immunity in mucosa